• Two Decades of Toremifene Citrate in Breast Cancer Therapy

  2026-04-30

  This review synthesizes twenty years of clinical and mechanistic data on Toremifene Citrate, highlighting its role as an oral selective estrogen receptor modulator in the management of hormone receptor-positive breast cancer. The findings support its efficacy, nuanced tissue selectivity, and pharmacokinetic distinctions from other SERMs, with implications for both experimental and clinical research.

• Triiodothyronine (T3): Applied Workflows in Metabolic Resear

  2026-04-30

  Triiodothyronine (T3) stands out as a high-purity, reproducible tool for dissecting thyroid hormone signaling and driving advanced metabolic assays. This article translates recent breakthroughs—such as SEMA3E’s role in beige adipocyte thermogenesis—into actionable protocols, troubleshooting guidance, and workflow optimizations, all leveraging APExBIO’s rigorously validated T3 reagent.

• Decoding mRNA Delivery: Mechanisms, Metrics & Translational

  2026-04-29

  Explore how dual-fluorescent, immune-evasive capped mRNA tools like EZ Cap™ Cy5 EGFP mRNA (5-moUTP) are unlocking new standards of quantification, reproducibility, and insight for translational gene delivery. This article bridges cutting-edge mechanistic findings, strategic assay design, and the evolving competitive landscape to equip researchers with actionable frameworks for next-generation mRNA therapeutics.

• ApexPrep DNA Plasmid Miniprep Kit: Precision in AML Research

  2026-04-29

  Explore how the ApexPrep DNA Plasmid Miniprep Kit delivers molecular biology grade plasmid DNA essential for cutting-edge acute myeloid leukemia (AML) research. This article uniquely bridges advanced plasmid prep with transcriptional regulation studies, revealing new assay insights.

• TSPAN18-Mediated STIM1 Stabilization Drives Bone Metastasis

  2026-04-28

  Zhou et al. uncover a novel mechanism linking TSPAN18 to enhanced bone metastasis in prostate cancer through the stabilization of STIM1 by preventing its TRIM32-mediated ubiquitination. This work highlights TSPAN18 as a promising therapeutic target and refines our understanding of calcium-dependent metastatic processes.

• Estradiol, ER Stress, and CD4+ T Cell Recovery After Hemorrh

  2026-04-28

  This study elucidates how 17β-estradiol (E2) restores splenic CD4+ T lymphocyte function after hemorrhagic shock via estrogen receptor-dependent inhibition of endoplasmic reticulum stress. The findings clarify the immunomodulatory role of ERα and GPR30, offering mechanistic insights relevant to trauma-induced immune suppression and endocrine therapy resistance research.

• Radicicol: Precision Hsp90 Inhibition for Adipogenesis and I

  2026-04-27

  Explore how Radicicol, a potent Hsp90 inhibitor, uniquely modulates adipogenesis, apoptosis, and inflammation in translational models. This article provides in-depth analysis of Radicicol's mechanisms, practical assay guidance, and its distinct value for advanced metabolic and cancer research.

• Protein A/G Magnetic Beads: Precision in Protein Interaction

  2026-04-27

  Accelerate antibody purification and protein interaction analysis with APExBIO's Protein A/G Magnetic Beads. Discover how these recombinant affinity particles streamline immunoprecipitation workflows, reduce background noise, and enable robust discovery in cancer stem cell research.

• Chloroquine: Multi-Target Mechanisms and Anticancer Innovati

  2026-04-26

  Explore the multifaceted actions of Chloroquine, a proven anti-inflammatory agent, as a research tool in cancer, malaria, and autoimmune models. This article uniquely analyzes advanced mechanistic insights and translational applications, offering more depth than standard assay guides.

• I-BET-762: Mechanistic Advances and Protocol Guidance for Tr

  2026-04-25

  This thought-leadership article blends mechanistic insight and strategic guidance for translational researchers exploring I-BET-762, a potent and selective BET inhibitor. Drawing on recent discoveries in ferroptosis, inflammation, and cancer biology, it synthesizes evidence, highlights actionable protocol parameters, and contextualizes APExBIO’s I-BET-762 within next-generation research workflows. The article escalates the discussion beyond standard product pages by integrating novel findings on BRD4 inhibition and ROS/FSP1 modulation, and offers a forward-looking perspective for translational applications.

• Nonivamide (Capsaicin Analog): Applied TRPV1 Activation in C

  2026-04-24

  Nonivamide, a potent capsaicin analog from APExBIO, enables researchers to dissect TRPV1-driven pathways in cancer and neuroimmune modulation. Its selective activity, robust anti-proliferative effects, and versatility in both in vitro and in vivo models make it a cornerstone for advanced oncology and inflammation studies.

• Chrysanthemum indicum L. Extract Induces Apoptosis in Glioma

  2026-04-24

  This study employs integrated network pharmacology, molecular docking, and both in vitro and in vivo experiments to elucidate the anti-glioma mechanisms of Chrysanthemum indicum L. extract (CIE). Key findings reveal that CIE targets androgen receptor signaling, inhibits glioma cell proliferation and migration, and induces apoptosis, substantiated by molecular and cellular assays.

• Organic Cation Transporter Response to Xenobiotics in Aedes

  2026-04-23

  Kennel and Rouhier’s 2025 study investigates how Aedes aegypti mosquitoes respond physiologically and at the gene expression level to injected synthetic dyes, including Olsalazine Sodium, with a focus on putative organic cation transporters. Their results highlight the nuanced effects of xenobiotic molecular structure on excretion and mortality, providing a foundation for targeting transporter mechanisms in mosquito control.

• Perospirone Inhibits Kv1.5 Channels in Vascular Smooth Muscl

  2026-04-23

  This study reveals that Perospirone, a second-generation antipsychotic, directly inhibits vascular Kv1.5 potassium channels in coronary arterial smooth muscle cells. These findings highlight a previously unrecognized off-target cardiovascular effect, with implications for both schizophrenia research and vascular pharmacology.

• Pentoxifylline Suppresses LPS-Induced Hyperinflammation in P

  2026-04-22

  Schüller et al. present an in vitro analysis of pentoxifylline's immunomodulatory effects on LPS-stimulated monocytes from preterm neonates, term infants, and adults. Their work reveals PTX's age-dependent attenuation of key surface markers, cytokine release, and TLR4 signaling, highlighting mechanistic differences in neonatal immune responses and informing future strategies for managing neonatal sepsis.

16792 records 1/1120 page Next 12345 下5页 Last page